Status:
COMPLETED
ACY-6 Oral Administration of Acyline
Lead Sponsor:
University of Washington
Collaborating Sponsors:
Merrion Pharmaceuticals, LLC
Conditions:
Contraception
Eligibility:
MALE
18-50 years
Phase:
PHASE1
Brief Summary
In this study, we propose oral dosing of GIPET enhanced oral acyline (MER-104) to determine if this potentially useful compound is safe and effective at suppression of gonadotropins after oral dosing ...
Detailed Description
The purpose of this study is to test how the body responds to a new oral form of acyline and to also look at the safety of oral acyline. Acyline temporarily blocks the production of the hormone testo...
Eligibility Criteria
Inclusion
- Males between 18-50 years of Age in good health
Exclusion
- Men in poor health, significant chronic or acute medical illness, known history of alcohol, illicit drug or anabolic steroid abuse
Key Trial Info
Start Date :
June 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2007
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT00471185
Start Date
June 1 2007
End Date
August 1 2007
Last Update
December 3 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Washington
Seattle, Washington, United States, 98195